Primary Objectives:
- To evaluate the results of Paclitaxel and pelvic radiation in pelvic confined papillary
serous carcinoma of the endometrium for both local control and overall survival.
- To evaluate the toxicity of Paclitaxel and pelvic radiation.
- To collect and evaluate patients' quality of life/symptom assessment data.